- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2197-7364
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Radiation dosimetry of [68Ga]PSMA-11 in low-risk prostate cancer patients ; volume:6 ; number:1 ; day:11 ; month:1 ; year:2019 ; pages:1-11 ; date:12.2019
EJNMMI Physics ; 6, Heft 1 (11.1.2019), 1-11, 12.2019
- Creator
-
Sandgren, Kristina
Johansson, Lennart
Axelsson, Jan
Jonsson, Joakim
Ögren, Mattias
Ögren, Margareta
Andersson, Martin
Strandberg, Sara
Nyholm, Tufve
Riklund, Katrine
Widmark, Anders
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40658-018-0239-2
- URN
-
urn:nbn:de:101:1-2019021321382173983491
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
01.08.20252025, 5:45 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Sandgren, Kristina
- Johansson, Lennart
- Axelsson, Jan
- Jonsson, Joakim
- Ögren, Mattias
- Ögren, Margareta
- Andersson, Martin
- Strandberg, Sara
- Nyholm, Tufve
- Riklund, Katrine
- Widmark, Anders
- SpringerLink (Online service)
Other Objects (12)
![[68Ga]Ga-PSMA-11: The First FDA-Approved 68Ga-Radiopharmaceutical for PET Imaging of Prostate Cancer](/assets/placeholder/searchResultMediaUnknown.png)
[68Ga]Ga-PSMA-11: The First FDA-Approved 68Ga-Radiopharmaceutical for PET Imaging of Prostate Cancer
Recurrent prostate cancer: combined role for MRI and PSMA-PET in 68Ga-PSMA-11 PET/MRI
68Ga-PSMA I&T PET/CT for primary staging of prostate cancer
44Sc-PSMA-617 for radiotheragnostics in tandem with 177Lu-PSMA-617—preclinical investigations in comparison with 68Ga-PSMA-11 and 68Ga-PSMA-617
68Ga-PSMA Cerenkov luminescence imaging in primary prostate cancer: first-in-man series
68Ga-PSMA I&T PET/CT for primary staging of prostate cancer [Abstract]
68Ga-PSMA PET/CT in early relapsed prostate cancer patients after radical therapy
68Ga-PSMA and 68Ga-FAPI radioligands in the diagnosis of tumors
The Role of 68Ga PSMA Imaging in Evaluating Adrenal Lesions in Prostate Cancer Patients
Cancers and Benign Processes on 68Ga PSMA PET-CT Imaging Other than Prostate Cancer
Metabolic response after 68Ga-PSMA-PET/CT-directed IGRT/SBRT for oligometastases prostate cancer
Systemic therapy response evaluation in prostate carcinoma with [68Ga]Ga-PSMA-11 PET/CT
[68Ga]Ga-PSMA-11: The First FDA-Approved 68Ga-Radiopharmaceutical for PET Imaging of Prostate Cancer
Recurrent prostate cancer: combined role for MRI and PSMA-PET in 68Ga-PSMA-11 PET/MRI
68Ga-PSMA I&T PET/CT for primary staging of prostate cancer
44Sc-PSMA-617 for radiotheragnostics in tandem with 177Lu-PSMA-617—preclinical investigations in comparison with 68Ga-PSMA-11 and 68Ga-PSMA-617
68Ga-PSMA Cerenkov luminescence imaging in primary prostate cancer: first-in-man series
68Ga-PSMA I&T PET/CT for primary staging of prostate cancer [Abstract]
68Ga-PSMA PET/CT in early relapsed prostate cancer patients after radical therapy
68Ga-PSMA and 68Ga-FAPI radioligands in the diagnosis of tumors
The Role of 68Ga PSMA Imaging in Evaluating Adrenal Lesions in Prostate Cancer Patients
Cancers and Benign Processes on 68Ga PSMA PET-CT Imaging Other than Prostate Cancer
Metabolic response after 68Ga-PSMA-PET/CT-directed IGRT/SBRT for oligometastases prostate cancer
Systemic therapy response evaluation in prostate carcinoma with [68Ga]Ga-PSMA-11 PET/CT
[68Ga]Ga-PSMA-11: The First FDA-Approved 68Ga-Radiopharmaceutical for PET Imaging of Prostate Cancer
Recurrent prostate cancer: combined role for MRI and PSMA-PET in 68Ga-PSMA-11 PET/MRI
68Ga-PSMA I&T PET/CT for primary staging of prostate cancer
44Sc-PSMA-617 for radiotheragnostics in tandem with 177Lu-PSMA-617—preclinical investigations in comparison with 68Ga-PSMA-11 and 68Ga-PSMA-617
68Ga-PSMA Cerenkov luminescence imaging in primary prostate cancer: first-in-man series
68Ga-PSMA I&T PET/CT for primary staging of prostate cancer [Abstract]
68Ga-PSMA PET/CT in early relapsed prostate cancer patients after radical therapy
68Ga-PSMA and 68Ga-FAPI radioligands in the diagnosis of tumors
The Role of 68Ga PSMA Imaging in Evaluating Adrenal Lesions in Prostate Cancer Patients
Cancers and Benign Processes on 68Ga PSMA PET-CT Imaging Other than Prostate Cancer
Metabolic response after 68Ga-PSMA-PET/CT-directed IGRT/SBRT for oligometastases prostate cancer